Abstract
PurposeThe S19-HCPs tool evaluates the stigma towards healthcare providers working with patients with COVID-19.Materials and MethodsThe psychometric properties of the Arabic and English versions of the S19-HCPs were examined. A survey using the S19-HCPs scale was administered online. Two reliability analyses were used in this study to identify the extent to which S19-HCPs shows consistent results (internal consistency and test–retest reliability). The English version of the scale was piloted on 33 Jordanian and the Arabic version on 27 Iraqi participants.ResultsThe internal consistency of the English and Arabic S19-HCPs was satisfactory (α = 0.79, 0.74, respectively). Two-week test–retest correlations were all statistically significant (ICC = 0.91, 0.89, respectively).ConclusionThe S19-HCPs is psychometrically robust and can be used in research assessing the stigma towards healthcare providers working with patients with COVID-19 in English and Arabic-speaking countries.
Highlights
Since December 2019, severe acute respiratory syndrome coronavirus-2 (SARSCoV-2), the novel coronavirus first detected in China (Wuhan, Hubei Province), which caused coronavirus disease 2019 (COVID-19), many developed and devel oping health care systems are facing unprecedented circumstances
The English version of the scale was piloted on (n = 33) from Jordan mostly 20–30 age group, and more than half the participants were nurses (n = 18; 55%) and females (n = 19; 58%), and more than half of the participants were working in COVID-19 designated facilities (n = 20; 60%), the vast majority did not receive any training related to stigma in general or even the one associated with COVID19 (n = 31; 94%)
The Arabic version of the scale was piloted on (n = 27) from Iraq mostly 20–30 age group, and more than the participants were nurses (n = 25; 93%) and females (n = 15; 56%), and more than half of the participants were working in COVID-19 designated facilities (n = 19; 70%), the vast majority did not receive any training related to stigma in general or even the one associated with COVID-19 (n = 23; 85%)
Summary
Since December 2019, severe acute respiratory syndrome coronavirus-2 (SARSCoV-2), the novel coronavirus first detected in China (Wuhan, Hubei Province), which caused coronavirus disease 2019 (COVID-19), many developed and devel oping health care systems are facing unprecedented circumstances. Examples of such challenges are, not limited to social, economic, and, most impor tantly, healthcare-related challenges.[1,2] The literature has focused on highlighting the catastrophic burdens of such a pandemic on the general population regarding its high morbidity and mortality rates.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
